Author

T. Brennan-Krohn

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

J. E. Kirby· 2 shared A. Grote· 1 shared A. M. Earl· 1 shared L. Friar· 1 shared S. Ditelberg· 1 shared S. Rodriguez· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 9 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

J. E. Kirby

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyAntimicrobial Agents and ChemotherapyPeer-reviewedMar 15, 2022

Transcriptomics reveals how minocycline-colistin synergy overcomes antibiotic resistance in multidrug-resistant Klebsiella pneumoniae

T. Brennan-Krohn, A. Grote, S. Rodriguez…·A. M. Earl

This paper identifies a synergistic antibiotic combination effective against multidrug-resistant Klebsiella pneumoniae and characterizes its transcriptional mechanisms.

DOI 10.1128/aac.01969-21

E. colibulk RNA-seq

𝕏 PostBluesky

MicrobiologybioRxivPreprintFeb 23, 2021

Synergistic Activity of Minocycline and Rifampin in Combination with Antifungal Drugs against Candida auris

T. Brennan-Krohn, L. Friar, S. Ditelberg, J. E. Kirby

The paper evaluates synergistic activity of minocycline and rifampin with antifungal drugs against Candida auris isolates using checkerboard and time-kill methods.

DOI 10.1101/2021.02.23.432620

experimental assaydrug response / drug discovery

𝕏 PostBluesky